Chronic lymphocytic leukaemia trials in Finland

2 trials · From EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/ MOIRAI)

  Where

  Helsinki, Tampere, Turku

  Age

  18 years and over

  People

  746 worldwide

  Run by

  University Of Cologne

  See details and how to join2023-510294-34-00 · EU 2023-510294-34-00
• Phase 3Taking people
  A long-term follow-up study for patients treated with Galapagos CAR T cell therapies

  Where

  Helsinki

  Age

  18 years and over

  People

  309 worldwide

  Run by

  Lakefront Biotherapeutics

  See details and how to join2023-510173-34-00 · EU 2023-510173-34-00